Drug Prices – Policy & Medicine

Sandoz Resolves Another Antitrust Settlement

The Limits of Prescription Drug Affordability Review Boards

CMS Readies for Round Two of Drug Price Negotiations

Minnesota’s 340B Program Report Sheds Light on Potential Abuses and Sparks Call for Reforms

CMS Releases Prices for Inflation Reduction Act Drug Price Negotiation Program

The Inflation Reduction Act (IRA) and Its Broader Impact on Innovation, Access, and Affordability in Healthcare

Congressional Budget Office Releases: Alternative Approaches to Reducing Prescription Drug Prices

Understanding the High Costs of Cancer Care: Insights from “Oncology Update with John Marshall”

Rare Disease Community Pushes Back Against Inflation Reduction Act

The 340B Program is Growing, But is it Benefitting Patients?